科林電氣(603050.SH)擬向全資一級子公司科林設備增資3億元
格隆匯6月18日丨科林電氣(603050.SH)公佈,公司於2020年6月18日以通訊表決方式召開了第三屆董事會第十九次會議,審議通過了《關於對全資一級子公司科林設備增資的議案》,同意公司用自有資金向全資一級子公司科林設備增資人民幣3億元,本次增資全部計入註冊資本。增資完成後,公司對科林設備的持股比例仍為100%。
科林設備作為科林電氣的重要子公司,其經營業績穩步增長,因科林設備自身發展需要實施本次增資,增資完成後有助於進一步增強科林設備核心產品技術革新、擴大產品產能、提升項目及訂單的承接能力,為公司及股東創造更大價值,符合公司長遠利益。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.